24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
93.75% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
6.25% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
67.98% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
29.21% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
1.69% |
|
ENZYME DYNAMICS |
1.12% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
54.46% |
|
INFLUENZA |
10.18% |
|
RCA OLIGOMERIC STABILITY MD SIMULATIONS |
8.38% |
|
ENZYME DYNAMICS |
6.99% |
|
CANCER |
5.38% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
4.42% |
|
ANTIBODY DYNAMICS SIMULATION |
2.46% |
|
RCA STABILITY TEMPERATURE SIMULATIONS |
1.69% |
|
RCA OLIGOMER STABILITY SIMULATIONS |
1.65% |
|
RCA OLIGOMERIC STABILITY HEAT STRESS SIMULATIONS |
.92% |
|
MEMBRANE TRANSPORT |
.88% |
|
RCA OLIGOMER STABILITY MD SIMULATIONS |
.88% |
|
RCA OLIGOMERIC STABILITY TEMPERATURE SIMULATION |
.85% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.38% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
.35% |
|
SUCROSE TRANSPORTER ATSUC1 |
.12% |